| AFP | Alpha(α) Feto-Protein [HP 1826, 1858, 1859, 2265] ; Oncofetal Antigens &nbs... |
|---|---|
| IDA | 1) Imino-Diacetic Acid 2) Iron Deficiency Anemia &nb... |
| ASGE | American Society for Gastrointestinal Endoscopy |
| AUGH | acute upper gastrointestinal hemorrhage |
| GE | gastric empyting; gastroemotional; gastroenteritis; gastroenterology; gastroenterostomy; gastroesoph... |
| GITS | GASTROINTESTINAL THERAPEUTIC SYSTEM |
|---|---|
| Gl | Gastrointestinal |
| GANT | Gastrointestinal autonomic nerve tumor |
| GIB | Gastrointestinal Bleeding |
| GIQLI | Gastrointestinal Quality of Life Index |
| glandular tularaemia | Tularaemia with predominant lymph node infection as main manifestation. (05 Mar 2000) |
|---|---|
| pulmonary tularaemia | Tularaemia affecting the lungs; tularaemic pneumonia. Synonym: pulmonic tularaemia. (05 Mar 2000) |
| pulmonic tularaemia | Tularaemia affecting the lungs; tularaemic pneumonia. Synonym: pulmonic tularaemia. (05 Mar 2000) |
| tularaemia | <infectious disease, microbiology> A rare infection of rabbits and rodents caused by the bacteria Francisella tularensis. Francisella tularensis is found in many animals (rabbits, rodents) and may be transmitted by direct contact or via insect bite (ticks and deer-fly). Humans can also contract the illness via the direct contact with the infected animal carcass (break in the skin). The illness is characterised by an ulcerative lesion at the site of the inoculation with regional lymph node swelling, pneumonia, fever, chills, headache, muscle pains and joint stiffness. Risk factors include an exposure to rabbits or recent tick bite. A vaccine is available for high risk workers. Treatment is with streptomycin or tetracycline. Tularaemia is fatal in 5% of untreated cases and in less than 1% of treated cases. Incidence: less than 200 cases per year (USA). Origin: Gr. Haima = blood (18 Jul 2002) |
| amyloidosis: gastrointestinal manifestations | <radiology> Oesophagus, loss of peristalsis, megaesophagus, stomach, small and rigid (simulate linitis plastica), effaced rugal pattern, diminished/absent peristalsis, may be localised to antrum, amyloidoma: well defined submucosal mass, small bowel, diffuse form (more common), diffuse, uniform thickening of valvulae conniventes, broadened flat undulated mucosal folds (mucosal atrophy), jejunalization of ileum, impaired motility, small bowel dilatation, localised form: multiple small deposits; associated with pseudoobstruction, colon, psudopolyps (12 Dec 1998) |
| gastrointestinal | <anatomy> Pertaining to or communicating with the stomach and intestine, as a gastrointestinal fistula. (18 Nov 1997) |
| gastrointestinal agents | Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (12 Dec 1998) |
| gastrointestinal bleeding | <gastroenterology> This describes any bleeding that may occur along the course of the gastrointestinal tract. This includes bleeding from the oesophagus, stomach, duodenum, small intestine, large intestine, rectum or anus. (12 Jan 1998) |
| gastrointestinal contents | The residue of ingested substances in the gastrointestinal tract. Excludes natural secretions and feces. (12 Dec 1998) |
| gastrointestinal fistula | A fistulous tract connecting the stomach with the intestine. (05 Mar 2000) |
| gastrointestinal haemorrhage | Bleeding in the gastrointestinal tract. (12 Dec 1998) |
| gastrointestinal hormone | <endocrinology> A general term for any hormone which is secreted by some part of the digestive system for the purpose of aiding digestion. For example: gastrin. (09 Oct 1997) |
| gastrointestinal hormones | Hormones that originate in and regulate motor and secretory activity of the digestive organs. (12 Dec 1998) |
| gastrointestinal tract | <anatomy> The gastrointestinal tract starts from the oral cavity and proceeds to the oesophagus, stomach, duodenum, small intestine, large intestine, rectum and anus. (12 Jan 1998) |
| gastrointestinal transit | Passage of food (sometimes in the form of a test meal) through the gastrointestinal tract as measured in minutes or hours. The rate of passage through the intestine is an indicator of small bowel function. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|